Building a world where technology prevents organ failure

We believe the next giant Healthcare companies will develop algorithms used in care just as pharma companies develop molecules used as treatments.

Our Story

Cibiltech is founded on technical excellence and a deep commitment to patients.

The Paris Transplant Group developed the first universal predictive algorithm for transplantation in 2018 after 20 years of research. Our iBox technology is based on the Paris Transplant Group’s renowned scientific excellence and decades of experience caring for our own transplant patients.
‍
We wanted to help patients worldwide by making our innovative technology available to everyone. With that goal, Alexandre Loupy, Xavier Jouven, and Stephane Tholander founded Cibiltech in 2019.

Together with a team of world-class scientists and business experts, we’re creating a world where science and technology work together in the service of human health.

Our Board
Our Team
SVP Chief Ethics & Business Integrity Officer Sanofi Group, Chairman of the Board Sanofi Switzerland, NED Chairman of the Board OrganX Foundation & also WHO Global Expert on Digit. Mr. Durand is a graduate of prestigious schools including an MBA University of Cambridge.
Dr. Julien Durand
Chairman of the board
Head of Financial Institutions Group France, Belgium & Luxembourg, BlackRock
Adrien De La Grange
Board Member
Alexandre Loupy, MD PhD, is the team leader of an epidemiology research team at the National Institute of Health and Medical Research (Inserm) U970. He is also a professor of Nephrology working​ in the kidney transplant department of Necker Hospital.
Pr. Alexandre Loupy
Board member
Pr Xavier Jouven is Head of the Cardiovascular departments of medical, surgical, prevention and rehabilitation, nephrology and metabolism of the Georges-Pompidou European Hospital, and Director of the research team integrative epidemiology of cardiovascular diseases, at INSERM-PARCC.
Pr. Xavier Jouven
Board member
Dr. Olivier Aubert is a nephrologist at the Department of Nephrology and Kidney Transplantation at Necker Hospital in Paris, France.
Dr. Olivier Aubert
Scientific Board
Nephrologist at the Nephrology and Kidney Transplantation Department, Saint-Louis Hospital-APHP, Paris, France and Professor of Nephrology at Paris Diderot University, France.
Pr. Carmen Lefaucheur
Scientific Board
A restructuring professional for over 15 years, Stéphane helps companies grow and reinvent themselves. Particularly sensitive to the issue of organ failure, he joined Cibiltech with the ambition of supporting its development for the benefit of patients.
Stéphane Hoareau
CEO
Jacques has been a professional in the field of innovative asset development (innovations resulting from academic research) for over 35 years and joins Cibiltech with the ambition of contributing to its transformation. He is particularly interested in the organ transplantation ecosystem.
Jacques Louis
COO
Head of Engineering, has over 12 years experience in web development. He worked in multiple activity area, such as Education, E-commerce, Marketing, Luxury…
Yaniv Afriat
Chief Technical Officer
Laure has over 20 years’ experience in clinical research acquired with medical device manufacturers of various sizes, as well as Clinical Research Organizations. She has managed and implemented worldwide the clinical strategy of early to late-stage trials in different therapeutics areas.
Laure Székely
CCO
David GAUTIER, head of partnership, has over 20 years experience in the fields of medtech and innovation. After a PhD in immunology (Pasteur inst.) he managed IT teams for many French public health actors, and then decrypt the european healthtech and AI fields as market analyst.
David Gautier
Head of Partnerships
After 10 years of experience in 360° Marketing within an international group, Charles moved into the health sector by taking over the management of a health-care Centre for 4 years. He is now putting his two areas of expertise in Marketing and Health to good use at Cibiltech !
Charles Brioix
Chief Marketing Officer
Ali Bellamine
Chief Data and Science Integration
François Brunhes
DevOps
Alexis Hayat
Web Developer
Manon Thiberge
Quality Engineer
Victoria Hemzacek
Strategic Development Manager
Rozenn Cabioch
Junior Clinical Project Manager
Charline Mazou
Telemedicine nurse
Mathias Drouet-Tatin
Telemedicine Nurse
Arnaud Doubremelle
Web Developer
Valentin Bensamon
Web developer
Emma Chauvet
Product Manager
Yassine Khachlek
Web Developer
Rami Ismail
Web Developer
Eloge Katasi
Office Manager
Raphaël Assuline
Web Developer
Quentin Cherifi
DevOps
Nahima Gueblaoui
Telemedicine nurse
Loubna Bargattou
Regulatory Quality Engineer
Sara Mafueni
Financial and Administrative Officer

Centered on the wellbeing of patients

Compassion
We are dedicated to helping others when they are in difficulty and making everyone feel useful and valued.
Usefulness
Our goal is to prevent organ failure to preserve life and ensure the resilience of the healthcare system.
Agility
We have the ability to adapt quickly and efficiently to different innovation challenges in constantly changing environments.
Perseverance
We are determined to complete our projects, even if obstacles and barriers may occur.

Our story

Feb. 2019: Creation of Cibiltech

Cibiltech was founded to take a leap into the future of transplantation

Mar. 2019: Collaboration with CareDX

Collaboration with CareDX provides prognostic information on allograft survival on the American Market

Dec. 2019: Paris Innovation Grand Prix

The 2019 year ended with the prestigious Paris Innovation Grand Prix being awarded to Cibiltech in E-Health category

Jun. 2020: EIT Health Laureate

Cibiltech was announced among the 2020 winners of EIT Health's bridgehead global program

Jan. 2021: Predigraft platform launch

Launch in France for kidney transplanted patients

Apr. 2021: Health Tech Award

Finalist to the Nobel Project's Health Tech Award

May 2021: Class IIa Marking

Predigraft received CE marking as a class IIa under the MDR for kidney transplanted patients

Jul. 2021 : + 1000 patients

A new significant milestone for Cibiltech with more than 1000 patients using our app

Feb. 2022: 1st patient enrolled in our Clinical Trial

First patient enrolled in our International Clinical Trial for monitoring kidney Transplant patients using AI

Mar. 2023: AI Award

Cibiltech announced as winner of the AI Award funded by the AAC and the NIHR